IV thrombolysis and renal function

被引:69
作者
Gensicke, Henrik [1 ]
Zinkstok, Sanne M. [2 ]
Roos, Yvo B. [2 ]
Seiffge, David J. [1 ]
Ringleb, Peter [3 ]
Artto, Ville [4 ]
Putaala, Jukka [4 ]
Haapaniemi, Elena [4 ]
Leys, Didier [5 ]
Bordet, Regis [5 ]
Michel, Patrik [6 ,7 ]
Odier, Celine [6 ,7 ]
Berrouschot, Joerg [8 ]
Arnold, Marcel [9 ]
Heldner, Mirjam R. [9 ]
Zini, Andrea [10 ]
Bigliardi, Guido [10 ]
Padjen, Visnja [11 ]
Peters, Nils [1 ]
Pezzini, Alessandro [12 ]
Schindler, Christian [13 ]
Sarikaya, Hakan [9 ,14 ]
Bonati, Leo H. [1 ]
Tatlisumak, Turgut [4 ]
Lyrer, Philippe A. [1 ]
Nederkoorn, Paul J. [2 ]
Engelter, Stefan T. [1 ]
机构
[1] Univ Basel Hosp, Dept Neurol, Basel, Switzerland
[2] Univ Amsterdam, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands
[3] Heidelberg Univ, D-69115 Heidelberg, Germany
[4] Univ Helsinki, Cent Hosp, FIN-00014 Helsinki, Finland
[5] Univ Lille North France, UDSL EA1046, Lille, France
[6] CHU Vaudois, Lausanne, Switzerland
[7] Univ Lausanne, CH-1015 Lausanne, Switzerland
[8] Municipal Hosp Altenburg, Altenburg, Germany
[9] Univ Hosp Bern, Bern, Switzerland
[10] AUSL Modena, Modena, Italy
[11] Univ Belgrade, Sch Med, Ctr Clin, Belgrade 11001, Serbia
[12] Univ Hosp Brescia, Brescia, Italy
[13] Univ Basel, Swiss Trop & Publ Hlth Inst, CH-4003 Basel, Switzerland
[14] Univ Zurich Hosp, Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
ACUTE ISCHEMIC-STROKE; GLOMERULAR-FILTRATION-RATE; LONG-TERM; KIDNEY-FUNCTION; DYSFUNCTION; RISK; OUTCOMES; THERAPY; EQUATION; SURVIVAL;
D O I
10.1212/01.wnl.0000435550.83200.9e
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Objective: To investigate the association of renal impairment on functional outcome and complications in stroke patients treated with IV thrombolysis (IVT). Methods: In this observational study, we compared the estimated glomerular filtration rate (GFR) with poor 3-month outcome (modified Rankin Scale scores 3-6), death, and symptomatic intracranial hemorrhage (sICH) based on the criteria of the European Cooperative Acute Stroke Study II trial. Unadjusted and adjusted odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. Patients without IVT treatment served as a comparison group. Results: Among 4,780 IVT-treated patients, 1,217 (25.5%) had a low GFR (<60mL/min/1.73 m(2)). A GFR decrease by 10 mL/min/1.73 m(2) increased the risk of poor outcome (OR [95% CI]): (ORunadjusted 1.20 [1.17-1.24]; ORadjusted 1.05 [1.01-1.09]), death (ORunadjusted 1.33 [1.28-1.38]; ORadjusted 1.18 [1.11-1.249]), and sICH (ORunadjusted 1.15 [1.01-1.22]; ORadjusted 1.11 [1.04-1.20]). Low GFR was independently associated with poor 3-month outcome (ORadjusted 1.32 [1.10-1.58]), death (ORadjusted 1.73 [1.39-2.14]), and sICH (ORadjusted 1.64 [1.21-2.23]) compared with normal GFR (60-120 mL/min/1.73 m(2)). Low GFR (ORadjusted 1.64 [1.21-2.23]) and stroke severity (ORadjusted 1.05 [1.03-1.07]) independently determined sICH. Compared with patients who did not receive IVT, treatment with IVT in patients with low GFR was associated with poor outcome (ORadjusted 1.79 [1.41-2.25]), and with favorable outcome in those with normal GFR (ORadjusted 0.77 [0.63-0.94]). Conclusion: Renal function significantly modified outcome and complication rates in IVT-treated stroke patients. Lower GFR might be a better risk indicator for sICH than age. A decrease of GFR by 10 mL/min/1.73 m(2) seems to have a similar impact on the risk of death or sICH as a 1-point-higher NIH Stroke Scale score measuring stroke severity.
引用
收藏
页码:1780 / 1788
页数:9
相关论文
共 30 条
[1]
CLASSIFICATION OF SUBTYPE OF ACUTE ISCHEMIC STROKE - DEFINITIONS FOR USE IN A MULTICENTER CLINICAL-TRIAL [J].
ADAMS, HP ;
BENDIXEN, BH ;
KAPPELLE, LJ ;
BILLER, J ;
LOVE, BB ;
GORDON, DL ;
MARSH, EE ;
KASE, CS ;
WOLF, PA ;
BABIKIAN, VL ;
LICATAGEHR, EE ;
ALLEN, N ;
BRASS, LM ;
FAYAD, PB ;
PAVALKIS, FJ ;
WEINBERGER, JM ;
TUHRIM, S ;
RUDOLPH, SH ;
HOROWITZ, DR ;
BITTON, A ;
MOHR, JP ;
SACCO, RL ;
CLAVIJO, M ;
ROSENBAUM, DM ;
SPARR, SA ;
KATZ, P ;
KLONOWSKI, E ;
CULEBRAS, A ;
CAREY, G ;
MARTIR, NI ;
FICARRA, C ;
HOGAN, EL ;
CARTER, T ;
GURECKI, P ;
MUNTZ, BK ;
RAMIREZLASSEPAS, M ;
TULLOCH, JW ;
QUINONES, MR ;
MENDEZ, M ;
ZHANG, SM ;
ALA, T ;
JOHNSTON, KC ;
ANDERSON, DC ;
TARREL, RM ;
NANCE, MA ;
BUDLIE, SR ;
DIERICH, M ;
HELGASON, CM ;
HIER, DB ;
SHAPIRO, RA .
STROKE, 1993, 24 (01) :35-41
[2]
In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke [J].
Agrawal, Varun ;
Rai, Baroon ;
Fellows, Jonathan ;
McCullough, Peter A. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (04) :1150-1157
[3]
Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
[4]
[Anonymous], 2003, COCHRANE DB SYST REV
[5]
Acute Ischemic Stroke in Children versus Young Adults [J].
Bigi, Sandra ;
Fischer, Urs ;
Wehrli, Edith ;
Mattle, Heinrich P. ;
Boltshauser, Eugen ;
Buerki, Sarah ;
Jeannet, Pierre-Yves ;
Fluss, Joel ;
Weber, Peter ;
Nedeltchev, Krassen ;
El-Koussy, Marwan ;
Steinlin, Maja ;
Arnold, Marcel .
ANNALS OF NEUROLOGY, 2011, 70 (02) :245-254
[6]
IV thrombolysis and statins [J].
Engelter, S. T. ;
Soinne, L. ;
Ringleb, P. ;
Sarikaya, H. ;
Bordet, R. ;
Berrouschot, J. ;
Odier, C. ;
Arnold, M. ;
Ford, G. A. ;
Pezzini, A. ;
Zini, A. ;
Rantanen, K. ;
Rocco, A. ;
Bonati, L. H. ;
Kellert, L. ;
Strbian, D. ;
Stoll, A. ;
Meier, N. ;
Michel, P. ;
Baumgartner, R. W. ;
Leys, D. ;
Tatlisumak, T. ;
Lyrer, P. A. .
NEUROLOGY, 2011, 77 (09) :888-895
[7]
Intravenous Thrombolysis in Stroke Attributable to Cervical Artery Dissection [J].
Engelter, Stefan T. ;
Rutgers, Matthieu P. ;
Hatz, Florian ;
Georgiadis, Dimitrios ;
Fluri, Felix ;
Sekoranja, Lucka ;
Schwegler, Guido ;
Mueller, Felix ;
Weder, Bruno ;
Sarikaya, Hakan ;
Luethy, Regina ;
Arnold, Marcel ;
Nedeltchev, Krassen ;
Reichhart, Marc ;
Mattle, Heinrich P. ;
Tettenborn, Barbara ;
Hungerbuehler, Hansjoerg J. ;
Sztajzel, Roman ;
Baumgartner, Ralf W. ;
Michel, Patrik ;
Lyrer, Philippe A. .
STROKE, 2009, 40 (12) :3772-3776
[8]
Restenosis after carotid endarterectomy: significance of newly acquired risk factors [J].
Fluri, F. ;
Hatz, F. ;
Voss, B. ;
Lyrer, P. A. ;
Engelter, S. T. .
EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 (03) :493-498
[9]
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J].
Go, AS ;
Chertow, GM ;
Fan, DJ ;
McCulloch, CE ;
Hsu, CY .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) :1296-1305
[10]
Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].
Hacke, W ;
Kaste, M ;
Fieschi, C ;
von Kummer, R ;
Davalos, A ;
Meier, D ;
Larrue, V ;
Bluhmki, E ;
Davis, S ;
Donnan, G ;
Schneider, D ;
Diez-Tejedor, E ;
Trouillas, P .
LANCET, 1998, 352 (9136) :1245-1251